New patent expiration for Novo Nordisk drug XULTOPHY 100/3.6

Annual Drug Patent Expirations for XULTOPHY+100%2F3.6 Xultophy 100/3.6 is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from one supplier. There are… The post New patent expiration for Novo Nordisk drug XULTOPHY 100/3.6 appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: